Sentences with phrase «potential earnings level»

For seafarers living in India or the Philippines — the country that provides 25 % of the world's seafaring labour — the potential earnings level provides a standard of living in their home countries that is well in excess of what they could expect to achieve by taking employment ashore in those countries.

Not exact matches

Actual results, including with respect to our targets and prospects, could differ materially due to a number of factors, including the risk that we may not obtain sufficient orders to achieve our targeted revenues; price competition in key markets; the risk that we or our channel partners are not able to develop and expand customer bases and accurately anticipate demand from end customers, which can result in increased inventory and reduced orders as we experience wide fluctuations in supply and demand; the risk that our commercial Lighting Products results will continue to suffer if new issues arise regarding issues related to product quality for this business; the risk that we may experience production difficulties that preclude us from shipping sufficient quantities to meet customer orders or that result in higher production costs and lower margins; our ability to lower costs; the risk that our results will suffer if we are unable to balance fluctuations in customer demand and capacity, including bringing on additional capacity on a timely basis to meet customer demand; the risk that longer manufacturing lead times may cause customers to fulfill their orders with a competitor's products instead; the risk that the economic and political uncertainty caused by the proposed tariffs by the United States on Chinese goods, and any corresponding Chinese tariffs in response, may negatively impact demand for our products; product mix; risks associated with the ramp - up of production of our new products, and our entry into new business channels different from those in which we have historically operated; the risk that customers do not maintain their favorable perception of our brand and products, resulting in lower demand for our products; the risk that our products fail to perform or fail to meet customer requirements or expectations, resulting in significant additional costs, including costs associated with warranty returns or the potential recall of our products; ongoing uncertainty in global economic conditions, infrastructure development or customer demand that could negatively affect product demand, collectability of receivables and other related matters as consumers and businesses may defer purchases or payments, or default on payments; risks resulting from the concentration of our business among few customers, including the risk that customers may reduce or cancel orders or fail to honor purchase commitments; the risk that we are not able to enter into acceptable contractual arrangements with the significant customers of the acquired Infineon RF Power business or otherwise not fully realize anticipated benefits of the transaction; the risk that retail customers may alter promotional pricing, increase promotion of a competitor's products over our products or reduce their inventory levels, all of which could negatively affect product demand; the risk that our investments may experience periods of significant stock price volatility causing us to recognize fair value losses on our investment; the risk posed by managing an increasingly complex supply chain that has the ability to supply a sufficient quantity of raw materials, subsystems and finished products with the required specifications and quality; the risk we may be required to record a significant charge to earnings if our goodwill or amortizable assets become impaired; risks relating to confidential information theft or misuse, including through cyber-attacks or cyber intrusion; our ability to complete development and commercialization of products under development, such as our pipeline of Wolfspeed products, improved LED chips, LED components, and LED lighting products risks related to our multi-year warranty periods for LED lighting products; risks associated with acquisitions, divestitures, joint ventures or investments generally; the rapid development of new technology and competing products that may impair demand or render our products obsolete; the potential lack of customer acceptance for our products; risks associated with ongoing litigation; and other factors discussed in our filings with the Securities and Exchange Commission (SEC), including our report on Form 10 - K for the fiscal year ended June 25, 2017, and subsequent reports filed with the SEC.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

With embedded advising, career coaching, and hands - on learning along the path, they will be well informed about the jobs, careers, and potential earnings that await them upon completion of each successive level.

The metrics that track some of these trends - the level of profit margins in relation to sales growth, sector valuation, and a downward drifting earnings surprise rate - are currently highlighting potential intermediate - term risks on the earnings front.

However, LinkedIn is more attractive at current levels than Twitter as its potential earnings power is easier to determine and has greater visibility.

Conducting fundamental research focusing on balance sheets, earnings, growth potential and other key metrics, management attempts to identify companies that it believes have the ability to produce attractive levels of dividend income over time.

And if the business can be built back up to 2007 earnings levels, $ 1.42 per share (yes, that included the coal and minerals operations which have since been sold) and we ascribed a 10x multiple we might be looking at over $ 14.00 a share in market value, not a bad potential upside.

LPNs provide entry - level care and administrative support, so they do not have high earnings potential.

Also, and I need to be more patient on this, a recessionary environment is actually «exciting» — if it goes on long enough, investors give up, mark down share prices to v reasonable levels, and seem to completely forget what peak (and possibly future) earnings were — a potential multi-bagger situation.

That's because at current price levels and valuation multiples, LANC's long - term annual total return potential is only about 8.8 % to 10.8 % (1.8 % yield + 7 % to 9 % earnings growth).

I see this quite often with middle aged senior level executives in that field, like cornered dogs wanting to bark and bite at anything that is taking away their ever decreasing potential earnings.

In addition to the potential for higher earnings on cash value balances, policyholders of universal life contracts have flexibility in terms of the level of total death benefit, premium amounts paid and payment frequency.

«We recommend investors buy Facebook at current levels and see potential catalysts in earnings, a reasonable response from the Company, and the passage of the height of negative headline volume.»

Entry Level Graduate Sports Recruitment Consultant: London Salary: # 22,000 - # 25,000 Basic, OTE # 35,000 first year earnings with uncapped commission potential.

* Working across junior to senior level roles ranging from salaries of # 50,000 - # 300,000 * Great offices with over 40 staff * Award winning training programme As a trainee sports recruitment consultant you will be responsible for: * Building relationships and regularly consulting clients and candidates, to ensure their recruitment needs are met * Maintaining successful client / candidate relationships * Generating new business through business development * Candidate engagement; screening CV's, communicating and interviewing candidates to establish position suitability * Producing adverts for job opportunities * Hitting / surpassing targets to earn commission With uncapped commission potential and OTE earnings of # 35k 1st year earnings, # 70k 2nd year earnings and # 100k + 3rd year earnings the opportunity to earn a great salary is very real.

In the event of such voluntary unemployment or underemployment, the employment potential and probable earnings level of the parent shall be determined based upon his or her recent work history, occupational qualifications, and prevailing earnings level in the community if such information is available.